COMMUNIQUÉS West-GlobeNewswire

Atrion Corporation Declares Quarterly Cash Dividend
12/11/2018
ALLEN, Texas, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Atrion Corporation (Nasdaq: ATRI) today announced that its Board of Directors declared a quarterly cash dividend of $1.35 per share on the Company’s outstanding Common [...]
Sanofi: Disclosure of trading in own shares
12/11/2018
Attachment Reporting EN.pdf
Sanofi : Déclaration des transactions sur actions propres
12/11/2018
Pièce jointe Reporting FR.pdf
CFN Media Launches Regular Showcasing of Leading Cannabis Funds & Investment Bankers
12/11/2018
Seattle, WA, Nov. 12, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”, “CannabisFN”), the leading agency and financial media network dedicated to the worldwide cannabis industry, today [...]
Phase 2 Results for Madrigal’s MGL-3196 in Non-Alcoholic Steatohepatitis (NASH) Presented during Presidential Plenary Clinical Session of The Liver Meeting® 2018
12/11/2018
-- Statistically significantly more NASH resolution in MGL-3196 as compared with placebo in a Phase 2 clinical trial support MGL-3196 as a first- and potentially best-in class thyroid hormone receptor (THR) β-selective [...]
Managers’ transactions
12/11/2018
BioPorto A/S Managers' Transactions November 12, 2018 Company announcement no. 21 Managers’ transactions BioPorto A/S has received notification pursuant to article 19 of Regulation (EU) no. 596/2014 of the below [...]
Early close of fully subscribed private placement
12/11/2018
November 12, 2018 Announcement no. 20 Early close of fully subscribed private placement The Board of Directors of BioPorto A/S (BioPorto) decided on November 11, 2018 to partially exercise the authorization in article [...]
MediPharm Labs Corp. Receives Sales Licence from Health Canada
12/11/2018
TORONTO, Nov. 12, 2018 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (“ MediPharm Labs ” or the “ Company ”) (TSXV: LABS) is pleased to announce that its wholly-owned subsidiary, MediPharm Labs Inc., has received its sales [...]
Ossur Hf : Transactions in relation to share buyback program
12/11/2018
Announcement no. 66/2018 12 November 2018 Transactions in relation to share buyback program On 9 October 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 59/2018. The purpose of the share [...]
Abeona Therapeutics annonce ses résultats financiers et les faits marquants du troisième trimestre 2018
12/11/2018
Conférence téléphonique est organisée pour les investisseurs le lundi 12 novembre à 10h00 ET (16h00 CET) NEW YORK et CLEVELAND, 12 nov. 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq : ABEO), une société [...]
FIT Biotech Oy: FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants
12/11/2018
FIT Biotech Oy Company release November 12, 2018 at 5:45 PM EET FIT Biotech Oy's Board of Directors has decided on the issue of Convertible Notes and Warrants On December 22, 2017, the Board of Directors of FIT Biotech [...]
Jefferson and Teladoc Introduce First Telehealth Fellowship
12/11/2018
Academic influencer and market leader in virtual care partner to advance telehealth PURCHASE, NY, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in virtual care, today unveiled a [...]
Physeon Announces Enrollment of First Patient in US “VIVA” Trial for Veinplicity
12/11/2018
Important Milestone for Veinplicity Study SCHAFFHAUSEN, Switzerland, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Physeon GmbH (“Physeon” or the “Company”), a leading developer of medical technology products for venous access, [...]
Nemaura Medical to Present at the Stifel 2018 Healthcare Conference
12/11/2018
LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive, affordable and flexible continuous glucose monitor (CGM) for use by people with diabetes [...]
Mersana Therapeutics Presents Pre-clinical Data at AACR-NCI-EORTC on Two Additional, Proprietary Antibody Drug Conjugate Platforms and a Pre-clinical Update for XMT-1522 in Non-small Cell Lung Cancer
12/11/2018
CAMBRIDGE, Mass., Nov. 12, 2018 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ:MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates (ADCs [...]
Biodesix Test Predicts Response to Atezolizumab in Lung Cancer
12/11/2018
Researchers Present New Data from Blood-Based Proteomic Test in Biomarkers and Immune Monitoring at SITC 2018 BOULDER, Colo. and WASHINGTON, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Researchers with Biodesix ® and Genentech, a [...]
Corvus Pharmaceuticals to Present at the 27th Annual Credit Suisse Healthcare Conference
12/11/2018
BURLINGAME, Calif., Nov. 12, 2018 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company focused on the development and commercialization of precisely targeted [...]
Vaccinex, Inc. Presents Overview of the Clinical Development of VX15 (pepinemab) for the Potential Treatment of Huntington’s Disease at the Huntington Study Group’s 2018 Annual Meeting
12/11/2018
Presentation and Poster Include Previously Announced Results of Cohort A of SIGNAL Trial ROCHESTER, N.Y., Nov. 12, 2018 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company engaged [...]
CLS Holdings USA Announces City Trees Booth at MJBizCon
12/11/2018
Meet the City Trees Team at Booth #3913 City Trees Products Available in 35 Nevada Dispensaries City Trees Considers Expansion Beyond Nevada LAS VEGAS, Nov. 12, 2018 (GLOBE NEWSWIRE) -- CLS Holdings USA, Inc. (OTCQB: [...]

Pages